Centre of Evidence Based Dermatology
  • Print
   
   

STOP GAP trial on pyoderma gangrenosum featured in "NIHR Signal"

 

The STOP GAP trial comparing prednisolone and ciclosporin for pyoderma gangrenosum is now the subject of an "NIHR Signal".

NIHR Signals are "accessible, timely summaries of the most recent, relevant and important research". They are published every week on the NIHR Discover Portal.

Posted on Wednesday 14th October 2015

Centre of Evidence Based Dermatology

The University of Nottingham
King's Meadow Campus
Lenton Lane
Nottingham, NG7 2NR


telephone: +44 (0) 115 823 1048
email:cebd@nottingham.ac.uk